Related references
Note: Only part of the references are listed.Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer
Ryosuke Kita et al.
CLINICAL NUTRITION (2021)
Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis
Han-Yu Deng et al.
NUTRITION (2021)
Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer
Jongsoo Lee et al.
THORACIC CANCER (2021)
Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer
Byung Min Lee et al.
CANCERS (2021)
Myosteatosis and prognosis in cancer: Systematic review and meta-analysis
G. F. P. Aleixo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Chemotherapy-Induced Sarcopenia
Federico Bozzetti
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Liang-Kung Chen et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
Skeletal Muscle Mass Change During Chemotherapy: A Systematic Review and Meta-analysis
Min Kyeong Jang et al.
ANTICANCER RESEARCH (2020)
The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study
Raila Aro et al.
EJSO (2020)
Nutrition interventions to treat low muscle mass in cancer
Carla M. Prado et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
The effects of sarcopenia and sarcopenic obesity after pancreaticoduodenectomy in patients with pancreatic head cancer
Youngju Ryu et al.
HPB (2020)
Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab
Takuto Shimizu et al.
DIAGNOSTICS (2020)
Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer
Song Ee Park et al.
SCIENTIFIC REPORTS (2020)
Exercise Reduces the Resumption of Tumor Growth and Proteolytic Pathways in the Skeletal Muscle of Mice Following Chemotherapy
Edson Alves de Lima et al.
CANCERS (2020)
Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: A systematic review and meta-analysis
Jiajun Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Approaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review
Behrang Amini et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer
Oonagh M. Griffin et al.
PANCREATOLOGY (2019)
Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study
Jessica J. Hopkins et al.
WORLD JOURNAL OF SURGERY (2019)
Sarcopenia: A Time for Action. An SCWD Position Paper
Juergen Bauer et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy
Willemieke P. M. Dijksterhuis et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
Takayuki Shiroyama et al.
SCIENTIFIC REPORTS (2019)
Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance
Emer M. Guinan et al.
SUPPORTIVE CARE IN CANCER (2018)
Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non-small cell lung cancer
Kazutaka Kakinuma et al.
THORACIC CANCER (2018)
PARP-1 and PARP-2 activity in cancer-induced cachexia: potential therapeutic implications
Esther Barreiro et al.
BIOLOGICAL CHEMISTRY (2018)
Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
Cynthia Stretch et al.
PLOS ONE (2018)
Conference on 'What governs what we eat?' Postgraduate Symposium A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes
L. E. Daly et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2018)
Chemotherapy-induced muscle wasting: an update
Dario Coletti
EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY (2018)
Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia
Jeffrey S. Damrauer et al.
EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY (2018)
Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy
Kyoung-Min Cho et al.
ONCOTARGET (2017)
Cancer-induced muscle wasting: latest findings in prevention and treatment
Zaira Aversa et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer
Jessie A. Elliott et al.
ANNALS OF SURGERY (2017)
Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study)
Bette J. Caan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
Louise E. Daly et al.
BRITISH JOURNAL OF CANCER (2017)
Diagnostic criteria for cancer cachexia: data versus dogma
Lisa Martin
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2016)
Sarcopenia is an Independent Predictor of Severe Postoperative Complications and Long-Term Survival After Radical Gastrectomy for Gastric Cancer Analysis from a Large-Scale Cohort
Cheng-Le Zhuang et al.
MEDICINE (2016)
Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
Rafael Barreto et al.
ONCOTARGET (2016)
Muscle wasting associated with the long-term use of mTOR inhibitors
Bishal Gyawali et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2015)
Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia
Steven B. Heymsfield et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2015)
Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib
Frederick Moryoussef et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved
Ji-an Chen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer
Guro B. Stene et al.
ACTA ONCOLOGICA (2015)
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
Younak Choi et al.
PLOS ONE (2015)
Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
Madoka Kimura et al.
SUPPORTIVE CARE IN CANCER (2015)
Pharmacological Inhibition of Poly(ADP-Ribose) Polymerases Improves Fitness and Mitochondrial Function in Skeletal Muscle
Eija Pirinen et al.
CELL METABOLISM (2014)
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Liang-Kung Chen et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)
The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
Stephanie A. Studenski et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Helene Lanic et al.
LEUKEMIA & LYMPHOMA (2014)
Sarcopenia and Physical Function In Overweight Patients with Advanced Cancer
Carla M. M. Prado et al.
CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH (2013)
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors
Takahito Ito et al.
NEUROMUSCULAR DISORDERS (2013)
Body composition and outcome in patients undergoing resection of colorectal liver metastases
M. G. van Vledder et al.
BRITISH JOURNAL OF SURGERY (2012)
PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation
Peter Bai et al.
CELL METABOLISM (2011)
Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia
Roger A. Fielding et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2011)
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2010)
Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
Sami Antoun et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women
Matthew J. Delmonico et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2007)
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image
W Shen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Sarcopenia: Alternative definitions and associations with lower extremity function
AB Newman et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2003)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
Share Paper
